Effects of anti-diabetic treatments in type 2 diabetes and fatty liver disease

Medicine & Life Sciences

• Non-alcoholic Fatty Liver Disease 100%
• Fatty Liver 99%
• Liver Diseases 78%
• Type 2 Diabetes Mellitus 69%
• Sodium-Glucose Transporter 2 Inhibitors 44%
• Liver 39%
• Weight Loss 38%
• Bariatric Surgery 34%
• Thiazolidinediones 20%
• Incretins 20%
• Glucagon-Like Peptide-1 Receptor 20%
• Weights and Measures 19%
• Investigational Therapies 19%
• Noncommunicable Diseases 17%
• Metformin 16%
• Expert Testimony 16%
• Therapeutics 15%
• Weight Gain 14%
• Edema 12%
• PubMed 12%
• Insulin 10%